Clinical and Experimental Dermatology最新文献

筛选
英文 中文
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-02-03 DOI: 10.1093/ced/llaf062
Francesca Barei, Paolo Calzari, Elena Pezzolo, Maddalena Napolitano, Mariateresa Rossi, Mario Bruno Guanti, Francesca Caroppo, Anna Belloni Fortina, Cataldo Patruno, Anna Campanati, Tommaso Bianchelli, Giovanni Marco D'Agostino, Eustachio Nettis, Francesco Pugliese, Vincenzo Picone, Ilaria Trave, Emanuele Cozzani, Luca Stingeni, Katharina Hansel, Matilde Dall'Olio, Benedetta Galli, Rosa Coppola, Vincenzo Panasiti, Martina Maurelli, Giampiero Girolomoni, Michela Ortoncelli, Simone Ribero, Angelo V Marzano, Silvia Ferrucci
{"title":"Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience.","authors":"Francesca Barei, Paolo Calzari, Elena Pezzolo, Maddalena Napolitano, Mariateresa Rossi, Mario Bruno Guanti, Francesca Caroppo, Anna Belloni Fortina, Cataldo Patruno, Anna Campanati, Tommaso Bianchelli, Giovanni Marco D'Agostino, Eustachio Nettis, Francesco Pugliese, Vincenzo Picone, Ilaria Trave, Emanuele Cozzani, Luca Stingeni, Katharina Hansel, Matilde Dall'Olio, Benedetta Galli, Rosa Coppola, Vincenzo Panasiti, Martina Maurelli, Giampiero Girolomoni, Michela Ortoncelli, Simone Ribero, Angelo V Marzano, Silvia Ferrucci","doi":"10.1093/ced/llaf062","DOIUrl":"https://doi.org/10.1093/ced/llaf062","url":null,"abstract":"<p><strong>Background: </strong>Tralokinumab has demonstrated efficacy in the treatment atopic dermatitis (AD) in both clinical trials and real-world settings. However, limited data exists on the long-term use of tralokinumab in real-world settings.</p><p><strong>Objective: </strong>A multicentric Italian study, evaluating tralokinumab's drug survival (DS) and efficacy up to 18 months of treatment among 471 patients with severe AD was conducted.</p><p><strong>Methods: </strong>EASI (Eczema Area and Severity Index), P-NRS (Pruritus Numerical Rating Scale), SD-NRS (Sleep Disturbance NRS), DLQI (Dermatology Life Quality Index) and ADCT (Atopic Dermatitis Control Tool) were recorded up to 18 months of treatment. DS was analyzed using Kaplan-Meier methodic.</p><p><strong>Results: </strong>Overall DS rate was 81.5% at 12 months. A significant higher DS was found for females (p<0.001, log-rank=11.90), patients with negative family history (FH) of AD (p=0.015, log-rank=5.96) and patients ≥60-year-old (p=0.018; log-rank=5.6) when considering DS due to inefficacy. The study demonstrates a significant reduction in the clinical scores evaluated, with patients naïve to biologics or Janus kinase inhibitors (JAKi) showing a faster improvement. In the univariate regression analysis, females (p=0.038, OR=1.613; C.I. 1.026-2.534), having no atopic comorbidity (p=0.039; OR=1.692; C.I. 1.027-2.783), negative FH of AD (p=0.031; OR=1.665; C.I. 1.047-2.649) and not using concomitant systemic treatment in the previous months (p=0.003; OR=22.065; C.I. 2.803-173.691) were associated with an increased likelihood of reaching EASI-75. In the multivariate analysis, only the latter variable remained significant (p=0.004, OR=23.037, C.I. 2.793-190.052).</p><p><strong>Conclusion: </strong>A significant improvement in clinical scores was observed, with patients naïve to biologics or JAKi experiencing faster progress. Female sex, absence of atopic comorbidities, and a negative FH of AD were linked to a higher likelihood of achieving EASI-75 in the univariate analysis but lost significance in the multivariate analysis. For discontinuation due to inefficacy, patients aged 60 and older, females, and those with a negative FH of AD had significantly better survival rates.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simplifying nasal reconstruction after Mohs surgery: an algorithm based on review of over 400 cases.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-02-01 DOI: 10.1093/ced/llaf054
Alyssa Breneman, Megan H Trager, Anna Bowling, Emily R Gordon, Karlyn Pollack, Faramarz H Samie
{"title":"Simplifying nasal reconstruction after Mohs surgery: an algorithm based on review of over 400 cases.","authors":"Alyssa Breneman, Megan H Trager, Anna Bowling, Emily R Gordon, Karlyn Pollack, Faramarz H Samie","doi":"10.1093/ced/llaf054","DOIUrl":"https://doi.org/10.1093/ced/llaf054","url":null,"abstract":"<p><p>Literature on reconstruction techniques for post-Mohs nasal defects with particular emphasis on the unique properties of underlying skin is lacking. We aimed to develop an algorithm to simplify the approach to post-Mohs reconstruction of the nose based on defect size, location, and cutaneous features of the surrounding skin. Retrospective review of 404 patients who underwent post-Mohs nasal reconstruction by a single Mohs surgeon between 2018 and 2024 was conducted. Defects were divided into small, medium, and large sizes. Locations were categorized into 3 zones based on cutaneous characteristics. Frequency of reconstructive techniques based on defect size and location was analyzed. Trends towards specific repairs based on the cutaneous location and size of Mohs defects were utilized to develop an algorithm for reconstructive decision making. This algorithm was based on zones defined by cutaneous characteristics, and may serve as an initial guide for surgeons planning reconstruction of nasal defects.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GRASS-UK: The Global Register of Alopecia areata disease Severity and treatment Safety- United Kingdom: importance of real-world data in alopecia areata.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-02-01 DOI: 10.1093/ced/llaf055
Matthew Harries, Yusur Al-Nuaimi, Dmitri Wall, Anne Chandidzura, Shehnaz Ahmed, Nekma Meah
{"title":"GRASS-UK: The Global Register of Alopecia areata disease Severity and treatment Safety- United Kingdom: importance of real-world data in alopecia areata.","authors":"Matthew Harries, Yusur Al-Nuaimi, Dmitri Wall, Anne Chandidzura, Shehnaz Ahmed, Nekma Meah","doi":"10.1093/ced/llaf055","DOIUrl":"https://doi.org/10.1093/ced/llaf055","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143073709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-02-01 DOI: 10.1093/ced/llaf053
Qin-Xiao Wang, Hai-Yang He, Ying-Luo Niu, Sheng Fang
{"title":"Refractory eosinophilic pustular folliculitis treated with tofacitinib: a case series and literature review.","authors":"Qin-Xiao Wang, Hai-Yang He, Ying-Luo Niu, Sheng Fang","doi":"10.1093/ced/llaf053","DOIUrl":"https://doi.org/10.1093/ced/llaf053","url":null,"abstract":"<p><strong>Objectives: </strong>Eosinophilic pustular folliculitis (EPF) is an uncommon skin condition that presents as follicular papules or pustules. The treatment of EPF is challenging due to the high relapse rates. This study aimed to evaluate the efficacy and safety of tofacitinib as a treatment for EPF.</p><p><strong>Methods: </strong>We presented 3 patients with refractory EPF who had been successfully treated with tofacitinib at our clinic and conducted a literature review using the PubMed database to gain further insight into this promising therapy.</p><p><strong>Results: </strong>Our patients were effectively treated with tofacitinib. To date, only three patients with EPF treated with Janus kinase (JAK) inhibitors have been reported and reviewed: one treated with tofacitinib and two with abrocitinib. Complete remission was observed in all the above patients, with no adverse events or relapses reported during an average follow-up period of 4.3 months.</p><p><strong>Conclusion: </strong>Tofacitinib may be an emerging alternative treatment option for EFP patients. Larger randomized controlled studies are needed to confirm these findings.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143073772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
General dermatology & dermatology in primary health care.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf043
James Gaston, Anthony Moussa, John C Su, Benjamin S Daniel
{"title":"General dermatology & dermatology in primary health care.","authors":"James Gaston, Anthony Moussa, John C Su, Benjamin S Daniel","doi":"10.1093/ced/llaf043","DOIUrl":"https://doi.org/10.1093/ced/llaf043","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human ectoparasitoses by flat wasps of the genera Sclerodermus and Cephalonomia (Hymenoptera: Bethylidae).
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf041
Paolo Masini, Luca Stingeni, Gianandrea Salerno, Valerio Saitta, Celso O Azevedo, Manuela Rebora, Matteo Ornielli, Katharina Hansel, Leonardo Bianchi, Gabriele Casciola
{"title":"Human ectoparasitoses by flat wasps of the genera Sclerodermus and Cephalonomia (Hymenoptera: Bethylidae).","authors":"Paolo Masini, Luca Stingeni, Gianandrea Salerno, Valerio Saitta, Celso O Azevedo, Manuela Rebora, Matteo Ornielli, Katharina Hansel, Leonardo Bianchi, Gabriele Casciola","doi":"10.1093/ced/llaf041","DOIUrl":"https://doi.org/10.1093/ced/llaf041","url":null,"abstract":"<p><p>Flat wasps of the genera Sclerodermus and Cephalonomia (Hymenoptera: Bethylidae) are ectoparasitoids of larvae from various insect orders. They are important biological control agents against stored-product insect pests and xylophagous insects. In humans, these genera encompass species that are responsible for the emergence of sting lesions worldwide. Despite their importance for human health, there are very few reports in the literature that provide a comprehensive overview of this topic. This review, based on literature data and authors' personal experience, describes skin lesions induced by insect species belonging to the Sclerodermus and Cephalonomia genera, focusing on possible involved pathomechanism, diagnosis, therapeutic management, and environmental disinfestation.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The recent change in the BNF topical corticosteroid potency classification is not evidence-based.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf049
Andrew Affleck, Robert Dawe, Joerg Albrecht
{"title":"The recent change in the BNF topical corticosteroid potency classification is not evidence-based.","authors":"Andrew Affleck, Robert Dawe, Joerg Albrecht","doi":"10.1093/ced/llaf049","DOIUrl":"https://doi.org/10.1093/ced/llaf049","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence trends of pediatric psoriasis in 1990-2021: findings from the Global Burden of Disease Study 2021.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf050
Ling Jin, Jingyi Yang, Pengjie Wan, Ying Cheng
{"title":"Incidence trends of pediatric psoriasis in 1990-2021: findings from the Global Burden of Disease Study 2021.","authors":"Ling Jin, Jingyi Yang, Pengjie Wan, Ying Cheng","doi":"10.1093/ced/llaf050","DOIUrl":"https://doi.org/10.1093/ced/llaf050","url":null,"abstract":"<p><strong>Background: </strong>Pediatric psoriasis is a chronic inflammatory skin disease that poses unique challenges in diagnosis and management. While studies from high-income countries have reported rising incidence trends, global data on the incidence of pediatric psoriasis remain scarce.</p><p><strong>Objective: </strong>To provide a comprehensive description of pediatric psoriasis incidence at the global, regional, and national levels.</p><p><strong>Method: </strong>We analyzed data from the Global Burden of Disease Study 2021 to evaluate the incidence trends of pediatric psoriasis from 1990 to 2021. Incidence rates were stratified by age, sex, and sociodemographic index (SDI). Estimated annual percentage change (EAPC) was used to quantify the temporal trends.</p><p><strong>Results: </strong>In 2021, there were 664,100 cases of pediatric psoriasis globally, with an incidence rate of 33.0 per 100,000 children. Over the study period, the global incidence increased by 0.21% (95% CI 0.18-0.25%) per year, with more pronounced rises observed in low- and middle-SDI regions. The highest incidence rates were recorded in high-SDI regions, such as High-income North America (70.5 per 100,000) and Western Europe (67.5 per 100,000). Notably, the largest increases in incidence occurred in regions like Sub-Saharan Africa. At the national level, 189 countries/territories experienced significant increases in pediatric psoriasis incidence, while only five countries saw a decline. Incidence was higher in girls across all age groups, with the most pronounced rise in children under 5 years old.</p><p><strong>Conclusions: </strong>The incidence of pediatric psoriasis has significantly increased, particularly in low- and middle-SDI regions, underscoring the need for improved diagnosis, early intervention, and targeted public health strategies.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is a hybrid skin cancer surveillance service for organ transplant recipients feasible?: Lessons from the COVID-19 pandemic.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf045
Jaimie Oldham, Pia Tookey, Rebecca Morgan, Sharumilan Ravindran, Aaron Sosah, Zeeshaan-Ul Hasan, Rebeca Goiriz, Catherine Harwood
{"title":"Is a hybrid skin cancer surveillance service for organ transplant recipients feasible?: Lessons from the COVID-19 pandemic.","authors":"Jaimie Oldham, Pia Tookey, Rebecca Morgan, Sharumilan Ravindran, Aaron Sosah, Zeeshaan-Ul Hasan, Rebeca Goiriz, Catherine Harwood","doi":"10.1093/ced/llaf045","DOIUrl":"https://doi.org/10.1093/ced/llaf045","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of a Blistering Eruption in Skin of Colour.
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2025-01-31 DOI: 10.1093/ced/llaf039
Omar M E Ali, Ala Haqiqi, Rana Salem, Batoul Nasr, Philip Hampton
{"title":"A Case of a Blistering Eruption in Skin of Colour.","authors":"Omar M E Ali, Ala Haqiqi, Rana Salem, Batoul Nasr, Philip Hampton","doi":"10.1093/ced/llaf039","DOIUrl":"https://doi.org/10.1093/ced/llaf039","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信